These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 17582319

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA, Pietsch H, Walter J, Haider W, Frenzel T, Weinmann HJ.
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [Abstract] [Full Text] [Related]

  • 23. Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis.
    Richmond H, Zwerner J, Kim Y, Fiorentino D.
    Arch Dermatol; 2007 Aug; 143(8):1025-30. PubMed ID: 17709661
    [Abstract] [Full Text] [Related]

  • 24. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
    Canavese C, Mereu MC, Aime S, Lazzarich E, Fenoglio R, Quaglia M, Stratta P.
    J Nephrol; 2008 Aug; 21(3):324-36. PubMed ID: 18587720
    [Abstract] [Full Text] [Related]

  • 25. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Feb 23; 56(7):137-41. PubMed ID: 17318112
    [Abstract] [Full Text] [Related]

  • 26. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
    Rydahl C, Thomsen HS, Marckmann P.
    Invest Radiol; 2008 Feb 23; 43(2):141-4. PubMed ID: 18197066
    [Abstract] [Full Text] [Related]

  • 27. Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy: a primer for radiologists.
    Prasad SR, Jagirdar J.
    J Comput Assist Tomogr; 2008 Feb 23; 32(1):1-3. PubMed ID: 18303280
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Current status of gadolinium toxicity in patients with kidney disease.
    Perazella MA.
    Clin J Am Soc Nephrol; 2009 Feb 23; 4(2):461-9. PubMed ID: 19201920
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The impact of NSF on the care of patients with kidney disease.
    Abu-Alfa A.
    J Am Coll Radiol; 2008 Jan 23; 5(1):45-52. PubMed ID: 18180009
    [Abstract] [Full Text] [Related]

  • 32. Nephrogenic systemic fibrosis--implications for nephrologists.
    Saab G, Abu-Alfa A.
    Eur J Radiol; 2008 May 23; 66(2):208-12. PubMed ID: 18342470
    [Abstract] [Full Text] [Related]

  • 33. Mechanism of NSF: New evidence challenging the prevailing theory.
    Newton BB, Jimenez SA.
    J Magn Reson Imaging; 2009 Dec 23; 30(6):1277-83. PubMed ID: 19937925
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Gadolinium-containing MRI contrast agents: important variations on a theme for NSF.
    Kuo PH.
    J Am Coll Radiol; 2008 Jan 23; 5(1):29-35. PubMed ID: 18180006
    [Abstract] [Full Text] [Related]

  • 36. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis.
    High WA, Ayers RA, Chandler J, Zito G, Cowper SE.
    J Am Acad Dermatol; 2007 Jan 23; 56(1):21-6. PubMed ID: 17097388
    [Abstract] [Full Text] [Related]

  • 37. Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.
    Lemy AA, del Marmol V, Kolivras A, High WA, Matos C, Laporte M, Nortier JL.
    J Am Acad Dermatol; 2010 Sep 23; 63(3):389-99. PubMed ID: 20619488
    [Abstract] [Full Text] [Related]

  • 38. Nephrogenic systemic fibrosis.
    Bardin T, Richette P.
    Curr Opin Rheumatol; 2010 Jan 23; 22(1):54-8. PubMed ID: 19881349
    [Abstract] [Full Text] [Related]

  • 39. [Nephrogenic systemic fibrosis and use of MR contrast media].
    Christiansen RE, Sviland L, Sekse I, Svarstad E.
    Tidsskr Nor Laegeforen; 2009 Jan 29; 129(3):180-2. PubMed ID: 19180161
    [Abstract] [Full Text] [Related]

  • 40. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL, Thakral C, Skov L, Rossen K, Marckmann P.
    Br J Dermatol; 2008 Feb 29; 158(2):273-80. PubMed ID: 18067485
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.